Lv6
1730 积分 2022-08-30 加入
Cancer progression and tumor hypercoagulability: a platelet perspective
1个月前
已完结
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
2个月前
已完结
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer
3个月前
已完结
Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity
4个月前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
4个月前
已完结
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
4个月前
已完结
A Parallel Dose-Escalation Study of Weekly and Twice-Weekly Bortezomib in Combination with Gemcitabine and Cisplatin in the First-Line Treatment of Patients with Advanced Solid Tumors
4个月前
已完结
Randomized Phase II Study of Bortezomib Alone and Bortezomib in Combination With Docetaxel in Previously Treated Advanced Non–Small-Cell Lung Cancer
5个月前
已完结
Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer
6个月前
已完结
Bone marrow inflammation in haematological malignancies
6个月前
已完结
皖公网安备34019202002308
